PortfoliosLab logoPortfoliosLab logo
PTCT vs. THC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PTCT vs. THC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PTC Therapeutics, Inc. (PTCT) and Tenet Healthcare Corporation (THC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PTCT achieves a -10.47% return, which is significantly lower than THC's 28.21% return. Over the past 10 years, PTCT has outperformed THC with an annualized return of 27.78%, while THC has yielded a comparatively lower 24.90% annualized return.


PTCT

1D
-9.94%
1M
-18.37%
6M
-9.96%
YTD
-10.47%
1Y
30.46%
3Y*
18.70%
5Y*
12.15%
10Y*
27.78%
ALL TIME*
11.78%

THC

1D
0.81%
1M
25.06%
6M
34.60%
YTD
28.21%
1Y
61.16%
3Y*
49.16%
5Y*
28.81%
10Y*
24.90%
ALL TIME*
6.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$107.25M$139.40M$141.83M
$388.53M$322.77M$279.36M

PTCT vs. THC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PTCT
PTC Therapeutics, Inc.
-10.47%68.28%63.79%-27.80%-4.17%-34.74%27.07%39.95%105.76%52.89%
THC
Tenet Healthcare Corporation
28.21%57.43%67.04%54.89%-40.27%104.58%5.00%121.88%13.06%2.16%

Correlation

The correlation between PTCT and THC is 0.19, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.19

Correlation (3Y)
Balances recent behavior with more history.

0.23

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.26

Correlation (10Y)
Provides a long-term view across more market conditions.

0.25

Correlation (All Time)
Calculated using the full available price history since Jun 20, 2013

0.25

Fundamentals

Market Cap

PTCT:

$5.64B

THC:

$20.51B

EPS

PTCT:

-$0.45

THC:

$19.34

PS Ratio

PTCT:

5.77

THC:

1.05

Total Revenue (TTM)

PTCT:

$1.01B

THC:

$21.46B

Gross Profit (TTM)

PTCT:

$476.39M

THC:

$9.18B

EBITDA (TTM)

PTCT:

$62.53M

THC:

$4.88B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PTCT vs. THC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PTCT
PTCT Risk / Return Rank: 6666
Overall Rank
PTCT Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
PTCT Sortino Ratio Rank: 6565
Sortino Ratio Rank
PTCT Omega Ratio Rank: 6565
Omega Ratio Rank
PTCT Calmar Ratio Rank: 6868
Calmar Ratio Rank
PTCT Martin Ratio Rank: 6666
Martin Ratio Rank

THC
THC Risk / Return Rank: 8080
Overall Rank
THC Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
THC Sortino Ratio Rank: 8585
Sortino Ratio Rank
THC Omega Ratio Rank: 8181
Omega Ratio Rank
THC Calmar Ratio Rank: 7676
Calmar Ratio Rank
THC Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PTCT vs. THC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PTC Therapeutics, Inc. (PTCT) and Tenet Healthcare Corporation (THC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PTCTTHCDifference
Sharpe ratioReturn per unit of total volatility

-0.63

Sortino ratioReturn per unit of downside risk

-1.06

Omega ratioGain probability vs. loss probability

1.17

1.27

-0.10

Calmar ratioReturn relative to maximum drawdown

1.13

1.71

-0.58

Martin ratioReturn relative to average drawdown

2.24

3.90

-1.66

PTCT vs. THC - Sharpe Ratio Comparison

The current PTCT Sharpe Ratio is 0.71, which is lower than the THC Sharpe Ratio of 1.35. The chart below compares the historical Sharpe Ratios of PTCT and THC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PTCT vs. THC - Drawdown Comparison

The maximum PTCT drawdown since its inception was -94.60%, roughly equal to the maximum THC drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for PTCT and THC.


Loading charts...

Drawdown Indicators


PTCTTHCDifference

Max Drawdown

Largest peak-to-trough decline

-94.60%

-98.28%

+3.68%

Max Drawdown (1Y)

Largest decline over 1 year

-27.17%

-34.08%

+6.91%

Max Drawdown (3Y)

Largest decline over 3 years

-56.77%

-34.48%

-22.29%

Max Drawdown (5Y)

Largest decline over 5 years

-69.42%

-58.88%

-10.54%

Max Drawdown (10Y)

Largest decline over 10 years

-73.78%

-71.68%

-2.10%

Current Drawdown

Current decline from peak

-24.05%

-2.99%

-21.06%

Average Drawdown

Average peak-to-trough decline

-45.64%

-51.45%

+5.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.66%

14.90%

-1.24%

Volatility

PTCT vs. THC - Volatility Comparison

The current volatility for PTC Therapeutics, Inc. (PTCT) is 14.58%, while Tenet Healthcare Corporation (THC) has a volatility of 21.56%. This indicates that PTCT experiences smaller price fluctuations and is considered to be less risky than THC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PTCTTHCDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.58%

21.56%

-6.98%

Volatility (6M)

Calculated over the trailing 6-month period

32.59%

35.55%

-2.96%

Volatility (1Y)

Calculated over the trailing 1-year period

42.99%

43.24%

-0.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.15%

45.22%

+9.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

66.20%

56.63%

+9.57%

Dividends

PTCT vs. THC - Dividend Comparison

Neither PTCT nor THC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PTCT vs. THC - Financials Comparison

This section allows you to compare key financial metrics between PTC Therapeutics, Inc. and Tenet Healthcare Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

PTCT vs. THC - Profitability Comparison

The chart below illustrates the profitability comparison between PTC Therapeutics, Inc. and Tenet Healthcare Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

PTCT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, PTC Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 360.52M. Therefore, the gross margin over that period was 0.0%.

THC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Tenet Healthcare Corporation reported a gross profit of 882.00M and revenue of 5.37B. Therefore, the gross margin over that period was 16.4%.

PTCT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, PTC Therapeutics, Inc. reported an operating income of 148.98M and revenue of 360.52M, resulting in an operating margin of 41.3%.

THC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Tenet Healthcare Corporation reported an operating income of 882.00M and revenue of 5.37B, resulting in an operating margin of 16.4%.

PTCT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, PTC Therapeutics, Inc. reported a net income of 83.50M and revenue of 360.52M, resulting in a net margin of 23.2%.

THC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Tenet Healthcare Corporation reported a net income of 702.00M and revenue of 5.37B, resulting in a net margin of 13.1%.


Frequently Asked Questions


PTCT and THC have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

THC has higher volatility (21.56%) compared to PTCT (14.58%). In terms of maximum drawdown, PTCT dropped -94.60% vs THC's -98.28%.

THC currently has the higher Sharpe Ratio (1.35 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PTCT and THC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer